Inhibition of metalloproteinases in therapy for severe lung injury due to COVID-19 there is no specific treatment for severe
acute lung injury (ALI) and ARDS due to the COVID-19 and the management
Cardamonin inhibits LPS-induced inflammatory responses and prevents acute lung injury by targeting myeloid differentiation factor 2Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. Background:
Acute lung injury (ALI) is a systemic inflammatory process, which has
Schisandrin B protects against LPS-induced inflammatory lung injury by targeting MyD88Zhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang Background:
Acute lung injury (ALI) is a challenging clinical syndrome that manifests as an
acute Aspiration-Induced Acute Lung Injury: Experimental Morphological Study>Conclusion. Acidin-pepsin aspiration leads to the development of
acute lung injury verified by morphological
Morphological Signs of Acute Lung Injury of Varying Etiology (Experimental Study)Objective: to reveal pulmonary morphological changes in
acute lung injury (ALI) of varying